Dr. Kavi Chakravarthi M G

PROFESSIONAL EDUCATION & REGISTRATIONS

1. DM (Medical Oncology)
   Sri Ramachandra Institute of Higher Education & Research – Chennai, India
2. MD (General Medicine)
   Sri Ramachandra Institute of Higher Education & Research – Chennai, India
   Thesis: Procalcitonin as a Marker of Sepsis
3. ECMO – European Certified in Medical Oncology
    European Society for Medical Oncalogy (ESMO)
4. MBBS
     Sri Ramachandra Medical College & Research Institute – Chennai, India

WORK EXPERIENCE

1.Senior Resident | Sri Balaji University – Chennai, India

Managed inpatient and outpatient care across oncology and internal medicine subspecialties.

Conducted daily ward rounds and clinical assessments.

Supervised junior trainees and coordinated multidisciplinary patient management.

2.Consulting Physician | Rela Hospital & Research Centre – Chennai, India

Delivered consultations in general medicine and oncology.

Managed complex multisystem medical cases requiring coordinated care.

 3.Consulting Physician | Venkateswara Hospital & M.G. Hospital

Provided OP/IP care in internal medicine and managed emergencies.

CLINICAL EXPERIENCE SUMMARY

Extensive exposure: Internal Medicine, Critical Care, Cardiology, Neurology, Nephrology, Pulmonology,Gastroenterology, Endocrinology, Oncology, Rheumatology, Psychiatry, Dermatology.

1. COVID ward and ICU management.
2. Multispecialty coordination in complex medical cases.

PUBLICATIONS & SKILLS

1. Procalcitonin as a Marker of Sepsis in ICU Care
2. Purple Bag Syndrome in Indwelling Foley Catheter
3. Case Series: Intra-pericardial Bleomycin in Malignant Pericardial Effusion.
4. Ewing Sarcoma of the Prostate – A Rare Case
5. Leiomyosarcoma of the Teslis – A Rare Case

Skills

1. Technical: Digital Oncology, Data Analytics, Radiomics, Al-enabled adherence systems (PillPal.ai).
2. Languages: English (Fluent), Tamil (Fluent), French (Basic).

CONFERENCE PRESENTATIONS & AWARDS

1. Oncology (2023-2026)
   OSCICON 2026: Real-world evidence of ICs in solid lumours.
   GVN 2025: Best Paper Award – Al-based oncology adherence study.
   ESMO Immune-Oncology 2025: Best Poster Award – Al to improve adherence.
   ESMO Asia 2024: Bleomycin in pericardial effusion (STS).
   National Conferences (2015-2017)
    APICON 2015/2016: Procalcitonin and Serum Magnesium studies.
    TAPICON 2015: Hepatopulmonary Syndrome & Thyroid Storm.